ArticleThe Journal of clinical investigation2022
Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
George Kunos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it